Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Property, Plant & Equipment (Net) · Q4 FY2024 · quarter ended Mar 2025
Property, plant & equipment (net) rises 31.3% from a year ago
Property, plant & equipment (net) stood at $1.21M at the end of Q4 FY2024, up 31.3% from a year earlier.
Context
- Property, plant & equipment (net) amounted to 22.6% of total assets at the end of Q4 FY2024, up 3.7 pp from a year earlier.
- Property, plant & equipment (net) increased in 1 of the last 2 fiscal years.
What to watch
Whether property, plant & equipment (net) keeps rising in the next quarterly balance sheet after a +31.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2024
- 1.21M USD
- Year-over-year change
- +31.3%
- 2-year CAGR
- -17.9%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 1.21M | +31.3% |
| FY2023 | 2024-03-31 | 921.86K | -48.7% |
| FY2022 | 2023-03-31 | 1.8M | — |
Property, Plant & Equipment (Net) vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 property, plant & equipment (net) of $1.21M is the 8th highest of the 10 companies compared; the peer median is $22.99M.
- Its year-over-year change of +31.3% is the 2nd highest of 10, against a peer median of -12.8%.
- Property, plant & equipment (net) amounts to 22.6% of total assets for MCTA, versus a peer median of 6.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $33.22M | -6.0% | +0.0% | 19.7% | |
| Mar 2026 | $30.13M | -20.4% | -7.3% | 2.0% | |
| Mar 2026 | $29.09M | -4.1% | +9.4% | 6.4% | |
| Mar 2026 | $24.87M | -12.8% | -10.5% | 9.5% | |
| Mar 2026 | $22.99M | -2.1% | +17.8% | 7.6% | |
| Mar 2026 | $18.51M | -14.2% | -11.6% | 6.8% | |
| Mar 2026 | $4.57M | +53.8% | +33.9% | 3.7% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $1.21M | +31.3% | — | 22.6% |
| Feb 2026 | $1.13M | -30.9% | -14.4% | 0.8% | |
| Mar 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding MCTA) | $22.99M | -12.8% | -3.7% | 6.4% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.